{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:00:23Z","timestamp":1778864423076,"version":"3.51.4"},"reference-count":169,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T00:00:00Z","timestamp":1456012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijpddr.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T04:38:41Z","timestamp":1463805521000},"page":"272-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Research for new drugs for elimination of onchocerciasis in Africa"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-1784","authenticated-orcid":false,"given":"Annette C.","family":"Kuesel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.04.002_bib1","first-page":"CD011146","article-title":"Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis","volume":"1","author":"Abegunde","year":"2016","journal-title":"Cochrane. Database. Syst. Rev."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib2","series-title":"2009 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2009"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib3","series-title":"2010 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2010"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib4","series-title":"African Programme for Onchocerciasis Control","article-title":"Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment","author":"African Programme for Onchocerciasis Control (APOC)","year":"2010"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib5","series-title":"2011 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2011"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib6","series-title":"2012 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2012"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib7","series-title":"Final Communiqu\u00e9 of the 18th Session of the Joint Action Forum (JAF18) of APOC","author":"African Programme for Onchocerciasis Control (APOC)","year":"2012"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib8","series-title":"2013 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2013"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib9","series-title":"2014 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2014"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib10","series-title":"2015 Progress ReportWorld Health Organization\/African Programme for Onchocerciasis Control","author":"African Programme for Onchocerciasis Control (APOC)","year":"2015"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib11","first-page":"661","article-title":"African programme for onchocerciasis control: progress report, 2014-2015","volume":"90","author":"African Programme for Onchocerciasis Control (APOC)","year":"2015","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2049-9957-2-25","article-title":"Assessing resources for implementing a community directed intervention (CDI) strategy in delivering multiple health interventions in urban poor communities in Southwestern Nigeria: a qualitative study","volume":"2","author":"Ajayi","year":"2013","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0035-9203(94)90109-0","article-title":"The first use of ivermectin for the treatment of onchocerciasis in Yemen","volume":"88","author":"Al-Qubati","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib14","first-page":"391","article-title":"Onchodermatitis (sowda) in patients in Yemen. Clinical and histologic course after treatment with ivermectin","volume":"7","author":"Al-Qubati","year":"1997","journal-title":"Sante"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0001-706X(02)00117-1","article-title":"Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis","volume":"84","author":"Ali","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib16","first-page":"179","article-title":"Loasis as a possible trigger of African endomyocardial fibrosis: a case report from Nigeria","volume":"38","author":"Andy","year":"1981","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib17","first-page":"381","article-title":"Progress towards eliminating onchocerciasis in the WHO region of the Americas: verification by WHO of elimination of transmission in Colombia","volume":"88","author":"Anonymous","year":"2013","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib18","first-page":"577","article-title":"Progress toward eliminating onchocerciasis in the WHO region of the Americas: verification of elimination of transmission in Mexico","volume":"90","author":"Anonymous","year":"2015","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00034983.1980.11687330","article-title":"The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides","volume":"74","author":"Awadzi","year":"1980","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib20","first-page":"213","article-title":"The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole","volume":"46","author":"Awadzi","year":"1995","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0035-9203(99)90305-X","article-title":"The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients","volume":"93","author":"Awadzi","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1179\/000349804225003442","article-title":"Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana","volume":"98","author":"Awadzi","year":"2004","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1179\/000349804225003253","article-title":"An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana","volume":"98","author":"Awadzi","year":"2004","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib24","first-page":"193","article-title":"Reactions to ivermectin treatment in onchocerciasis patients","volume":"59","author":"Awadzi","year":"1990","journal-title":"Acta Leiden."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/000349803235001697","article-title":"The co-administration of ivermectin and albendazole\u2013safety, pharmacokinetics and efficacy against Onchocerca volvulus","volume":"97","author":"Awadzi","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2125.1992.tb05632.x","article-title":"Diethylcarbamazine in the treatment of patients with onchocerciasis","volume":"34","author":"Awadzi","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib27","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pntd.0002953","article-title":"A\u00a0randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in onchocerca volvulus infection","volume":"8","author":"Awadzi","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"issue":"Suppl.\u00a0l.","key":"10.1016\/j.ijpddr.2016.04.002_bib28","article-title":"Is O.\u00a0volvulus suboptimal response to ivermectin a result of selection under ivermectin pressure? Insights from a study comparing ivermectin and moxidectin in areas without prior ivermectin mass treatment","volume":"89","author":"Bakajika","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0065-308X(08)00611-8","article-title":"Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus","volume":"68","author":"Basanez","year":"2009","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","article-title":"Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis","volume":"8","author":"Basanez","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1471-4922(01)02013-X","article-title":"Models for the population biology and control of human onchocerciasis","volume":"17","author":"Basanez","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib32","first-page":"26","article-title":"The onchocerciasis control program in West Africa (OCP): essential characteristics","volume":"8","author":"Benton","year":"1998","journal-title":"Sante"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bjo.64.3.191","article-title":"Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate","volume":"64","author":"Bird","year":"1980","journal-title":"Br. J. Ophthalmol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/136485908X337427","article-title":"The onchocerciasis control programme in West Africa (OCP)","volume":"102","author":"Boatin","year":"2008","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-308X(05)61009-3","article-title":"Control of onchocerciasis","volume":"61","author":"Boatin","year":"2006","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2307\/3283620","article-title":"Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unguiculatus)","volume":"79","author":"Bosshardt","year":"1993","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1179\/136485906X112194","article-title":"Loiasis","volume":"100","author":"Boussinesq","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib38","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2883-2-S1-S4","article-title":"Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","article-title":"Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis","volume":"58","author":"Boussinesq","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1756-3305-4-152","article-title":"Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria","volume":"4","author":"Brieger","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0272684X15592757","article-title":"The potential for community-directed interventions: reaching underserved populations in Africa","volume":"35","author":"Brieger","year":"2015","journal-title":"Int. Q.Community Health Educ."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2883-2-10","article-title":"Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa","volume":"2","author":"Buttner","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/138920112800399095","article-title":"History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents","volume":"13","author":"Campbell","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.parint.2009.07.006","article-title":"Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice","volume":"58","author":"Ceballos","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib45","doi-asserted-by":"crossref","first-page":"e2838","DOI":"10.1371\/journal.pntd.0002838","article-title":"Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations","volume":"8","author":"Ceballos","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib46","first-page":"405","article-title":"Progress toward elimination of onchocerciasis in the americas - 1993-2012","volume":"62","author":"Center for Disease Control (CDC)","year":"2013","journal-title":"MMWR Morb.Mortal.Wkly.Rep"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib47","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1073\/pnas.0906176106","article-title":"Identifying sub-optimal responses to ivermectin in the treatment of River Blindness","volume":"106","author":"Churcher","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4269\/ajtmh.1992.47.512","article-title":"Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela","volume":"47","author":"Cline","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib49","doi-asserted-by":"crossref","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","article-title":"Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment","volume":"9","author":"Coffeng","year":"2014","journal-title":"PLoS.One"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib50","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pntd.0002032","article-title":"African Programme for Onchocerciasis Control 1995-2015: model-estimated health impact and cost","volume":"7","author":"Coffeng","year":"2013","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib51","doi-asserted-by":"crossref","first-page":"e2759","DOI":"10.1371\/journal.pntd.0002759","article-title":"African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights","volume":"8","author":"Coffeng","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1358\/dnp.2010.23.1.1441464","article-title":"Accelerating drug development and approval","volume":"23","author":"Cole","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib53","series-title":"Research and Development in the Pharmaceutical Industry","author":"Congress of the United States - Congressional Budget Office","year":"2006"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1756-3305-6-289","article-title":"Interruption of onchocerca volvulus transmission in northern Venezuela","volume":"6","author":"Convit","year":"2013","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/0091270003257456","article-title":"The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans","volume":"43","author":"Cotreau","year":"2003","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib56","doi-asserted-by":"crossref","first-page":"e0004062","DOI":"10.1371\/journal.pntd.0004062","article-title":"The cyclooctadepsipeptide anthelmintic emodepside differentially modulates nematode, insect and human calcium-activated potassium (SLO) channel alpha subunits","volume":"9","author":"Crisford","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib57","doi-asserted-by":"crossref","first-page":"286re4","DOI":"10.1126\/scitranslmed.aaa3480","article-title":"Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope","volume":"7","author":"D\u2019Ambrosio","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2883-2-2","article-title":"Final report of the conference on the eradicability of Onchocerciasis","volume":"2","author":"Dadzie","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-5-1","article-title":"Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin","volume":"5","author":"Debrah","year":"2006","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/cid\/civ363","article-title":"Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: a randomized, placebo-controlled, double-blind trial","volume":"61","author":"Debrah","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib61","first-page":"375","article-title":"A\u00a0community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions","volume":"40","author":"DeSole","year":"1989","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib62","first-page":"707","article-title":"Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials","volume":"67","author":"DeSole","year":"1989","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib63","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal","volume":"3","author":"Diawara","year":"2009","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"Dimasi","year":"2003","journal-title":"J.Health Econ."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(83)92753-8","article-title":"Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis","volume":"1","author":"Dominguez-Vazquez","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00034983.1991.11812536","article-title":"Observations and reflections on the immature stages of Onchocerca volvulus in the human host","volume":"85","author":"Duke","year":"1991","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pt.2013.01.001","article-title":"New advancement in anthelmintic drugs in veterinary medicine","volume":"29","author":"Epe","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib68","doi-asserted-by":"crossref","first-page":"e0003542","DOI":"10.1371\/journal.pntd.0003542","article-title":"Managing the fight against onchocerciasis in Africa: APOC experience","volume":"9","author":"Fobi","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib69","series-title":"The FDA\u2019s Drug Review Process: Ensuring Drugs Are Safe and Effective","author":"Food and Drug Administration of the United States of America","year":"2012"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib70","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.1985.34.529","article-title":"The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity","volume":"34","author":"Francis","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/00034983.1987.11812173","article-title":"The chemotherapy of onchocerciasis. XII. The prediction of microfilarial loads in patients with onchocerciasis after treatment with diethylcarbamazine in northern Ghana","volume":"81","author":"Fulford","year":"1987","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib73","first-page":"247","article-title":"Preliminary results on the effect of tetracycline on the embryogenesis and symbiotic bacteria (Wolbachia) of Dirofilaria immitis. An update and discussion","volume":"40","author":"Genchi","year":"1998","journal-title":"Parassitologia"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00436-003-0872-z","article-title":"No evidence of Wolbachia endosymbiosis with Loa loa and Mansonella perstans","volume":"90","author":"Grobusch","year":"2003","journal-title":"Parasitol. Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib75","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s00436-005-1438-z","article-title":"Mechanisms of action of emodepside","volume":"97","author":"Harder","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib76","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0924-8579(03)00219-X","article-title":"Cyclooctadepsipeptides\u2013an anthelmintically active class of compounds exhibiting a novel mode of action","volume":"22","author":"Harder","year":"2003","journal-title":"Int. J.Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00436-002-0619-2","article-title":"Cyclooctadepsipeptides\u2013a new class of anthelmintically active compounds","volume":"88","author":"Harder","year":"2002","journal-title":"Parasitol. Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib78","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1475-2883-2-S1-S10","article-title":"Programmatic and communication issues in relation to serious adverse events following ivermectin treatment in areas Co-endemic for onchocerciasis and loiasis","volume":"2","author":"Haselow","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.13-0112","article-title":"Interruption of onchocerca volvulus transmission in the Abu Hamed focus, Sudan","volume":"89","author":"Higazi","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib80","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(00)04581-5","article-title":"Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment","volume":"357","author":"Hoerauf","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1286-4579(03)00026-1","article-title":"Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms","volume":"5","author":"Hoerauf","year":"2003","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00436-008-0964-x","article-title":"Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus","volume":"103","author":"Hoerauf","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00430-007-0062-1","article-title":"Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study","volume":"197","author":"Hoerauf","year":"2008","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00436-008-1217-8","article-title":"Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus","volume":"104","author":"Hoerauf","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib85","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(00)02095-X","article-title":"Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis","volume":"355","author":"Hoerauf","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(10)70094-3","article-title":"Operational research in low-income countries","volume":"10","author":"Horstick","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.ijpddr.2016.04.002_bib87","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1017\/S0031182000007423","article-title":"An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis","volume":"121","author":"Horton","year":"2000","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib88","series-title":"IFPMA Presentation to WHO Expert Working Group on Funding R&D for Diseases of the Developing World","author":"International Federation of Pharmaceutical Manufacturers & Associations","year":"2009"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpddr.2014.09.001","article-title":"Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis","volume":"4","author":"Johnston","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib90","doi-asserted-by":"crossref","first-page":"e0004492","DOI":"10.1371\/journal.pntd.0004492","article-title":"Effect of two or six doses 800 mg of albendazole every two months on loa loa microfilaraemia: a double blind, randomized, placebo-controlled trial","volume":"10","author":"Kamgno","year":"2016","journal-title":"PLoS.Negl. Trop. Dis."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.ijpddr.2016.04.002_bib91","first-page":"79","article-title":"Opthalmological findings from a study comparing the effect of a single dose of 150 microgram\/kg ivermectin and of 8 mg moxidectin on microfilariae levels in Onchocerca volvulus infections","volume":"89","author":"Kanza","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib92","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2015.11845","article-title":"Experience with the priority review voucher program for drug development","volume":"314","author":"Kesselheim","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib93","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat.Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/2160763X11432508","article-title":"Relative bioavailability of liquid and tablet formulations of the antiparasitic moxidectin","volume":"1","author":"Korth-Bradley","year":"2013","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4269\/ajtmh.2012.11-0415","article-title":"The effect of a high-fat breakfast on the pharmacokinetics of moxidectin in healthy male subjects: a randomized phase I trial","volume":"86","author":"Korth-Bradley","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib96","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/AAC.00311-11","article-title":"Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women","volume":"55","author":"Korth-Bradley","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cpdd.81","article-title":"Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects","volume":"3","author":"Korth-Bradley","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib98","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4269\/ajtmh.1977.26.663","article-title":"Intracytoplasmic bacteria in Onchocerca volvulus","volume":"26","author":"Kozek","year":"1977","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pt.2012.06.005","article-title":"Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action","volume":"28","author":"Krucken","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib100","doi-asserted-by":"crossref","first-page":"e3401","DOI":"10.1371\/journal.pntd.0003401","article-title":"Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside","volume":"8","author":"Kulke","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib101","doi-asserted-by":"crossref","first-page":"e0003688","DOI":"10.1371\/journal.pntd.0003688","article-title":"Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors","volume":"9","author":"Lamberton","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2012.12.004","article-title":"Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in\u00a0vitro","volume":"36","author":"Longo","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.reprotox.2014.06.009","article-title":"In\u00a0vivo preliminary investigations of the effects of the benzimidazole anthelmintic drug flubendazole on rat embryos and fetuses","volume":"49C","author":"Longo","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib104","doi-asserted-by":"crossref","first-page":"e2821","DOI":"10.1371\/journal.pntd.0002821","article-title":"Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution","volume":"8","author":"Lovato","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2883-5-6","article-title":"A\u00a0possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy","volume":"5","author":"Lukiana","year":"2006","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib106","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eri.11.30","article-title":"Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs","volume":"9","author":"Mackenzie","year":"2011","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib107","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1475-2883-2-S1-S5","article-title":"Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients","volume":"2","author":"Mackenzie","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pt.2011.10.003","article-title":"Elimination of onchocerciasis from Africa: possible?","volume":"28","author":"Mackenzie","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib109","series-title":"Recommendations for the Treatment of Onchocerciasis with Mectizan in Areas Co-endemic for Onchocerciasis and Loiasis","author":"Mectizan Expert Committee and APOC Technical Consultative Committee","year":"2004"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib110","doi-asserted-by":"crossref","first-page":"e2824","DOI":"10.1371\/journal.pntd.0002824","article-title":"Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naive and a frequently treated population from Cameroon","volume":"8","author":"Nana-Djeunga","year":"2014","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib111","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/1756-3305-7-325","article-title":"The geographic distribution of Onchocerciasis in the 20 participating countries of the African programme for Onchocerciasis control: (1) priority areas for ivermectin treatment","volume":"7","author":"Noma","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/154.1.10","article-title":"Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations","volume":"154","author":"Nutman","year":"1986","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib113","doi-asserted-by":"crossref","first-page":"e0004328","DOI":"10.1371\/journal.pntd.0004328","article-title":"Model-based geostatistical mapping of the prevalence of onchocerca volvulus in West Africa","volume":"10","author":"O\u2019Hanlon","year":"2016","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib114","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1371\/journal.pntd.0001138","article-title":"Potential drug development candidates for human soil-transmitted helminthiases","volume":"5","author":"Olliaro","year":"2011","journal-title":"PLoS.Negl. Trop. Dis."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib115","first-page":"58","article-title":"Efficacy of a single oral dose of 8 mg Moxidectin vs. 150 ug\/kg ivermectin in onchocerca volvulus infection: results of a randomized, double-blind single dose phase 3 study in areas without mass treatment with ivermectin in Liberia, Ghana and DRC","volume":"18","author":"Opoku","year":"2013","journal-title":"Trop.Med.Int Health"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib116","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus","volume":"5","author":"Osei-Atweneboana","year":"2011","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib117","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","article-title":"Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study","volume":"369","author":"Osei-Atweneboana","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib118","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-3156.2011.02783.x","article-title":"The African Programme for Onchocerciasis Control: impact on onchocercal skin disease","volume":"16","author":"Ozoh","year":"2011","journal-title":"Trop.Med.Int Health"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib119","series-title":"Drug Discovery and Development: Understanding the R&D Process","author":"Pharmaceutical Research and Manufacturers of America","year":"2007"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4269\/ajtmh.14-0661","article-title":"The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo","volume":"92","author":"Pion","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib121","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.actatropica.2010.05.004","article-title":"Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin","volume":"120","author":"Pion","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib122","doi-asserted-by":"crossref","first-page":"e2084","DOI":"10.1371\/journal.pntd.0002084","article-title":"Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naive and a multiply treated population from Cameroon","volume":"7","author":"Pion","year":"2013","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib123","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-2607(90)90030-D","article-title":"ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis","volume":"31","author":"Plaisier","year":"1990","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib124","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0001-706X(91)90015-C","article-title":"The reproductive lifespan of Onchocerca volvulus in West African savanna","volume":"48","author":"Plaisier","year":"1991","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","article-title":"Moxidectin and the avermectins: consanguinity but not identity","volume":"2","author":"Prichard","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib126","first-page":"667","article-title":"A\u00a0force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area","volume":"64","author":"Remme","year":"1986","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib127","first-page":"367","article-title":"A\u00a0community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus","volume":"40","author":"Remme","year":"1989","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib128","first-page":"331","article-title":"The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa","volume":"68","author":"Remme","year":"1990","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-3156.2003.01192.x","article-title":"Research for control: the onchocerciasis experience","volume":"9","author":"Remme","year":"2004","journal-title":"Trop.Med.Int. Health"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4269\/ajtmh.2007.77.878","article-title":"No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and\/or azithromycin","volume":"77","author":"Richards","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1377\/hlthaff.25.2.313","article-title":"Developing drugs for developing countries","volume":"25","author":"Ridley","year":"2006","journal-title":"Health Aff. (Millwood.)"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib132","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(10)60669-1","article-title":"Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases","volume":"376","author":"Ridley","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib133","doi-asserted-by":"crossref","first-page":"e1750","DOI":"10.1371\/journal.pntd.0001750","article-title":"The impact of the US priority review voucher on private-sector investment in global health research and development","volume":"6","author":"Robertson","year":"2012","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib134","doi-asserted-by":"crossref","first-page":"e0003922","DOI":"10.1371\/journal.pntd.0003922","article-title":"Elimination of onchocerciasis from Mexico","volume":"9","author":"Rodriguez-Perez","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib135","doi-asserted-by":"crossref","first-page":"e0003562","DOI":"10.1371\/journal.pntd.0003562","article-title":"40 Years of the APOC partnership","volume":"9","author":"Roungou","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib136","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3109\/03639045.2014.884132","article-title":"The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases","volume":"40","author":"Sachs-Barrable","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib137","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-2883-2-S1-S2","article-title":"Report of a scientific working group on serious adverse events following Mectizan(R) treatment of onchocerciasis in loa loa endemic areas","volume":"2","author":"Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib138","doi-asserted-by":"crossref","first-page":"e3378","DOI":"10.1371\/journal.pntd.0003378","article-title":"Applied research for better disease prevention and control","volume":"9","author":"Sommerfeld","year":"2015","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib139","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1467-8519.2009.01753.x","article-title":"In defence of priority review vouchers","volume":"23","author":"Sonderholm","year":"2009","journal-title":"Bioethics"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib140","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00436-008-1133-y","article-title":"Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus","volume":"103","author":"Specht","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib141","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13071-015-1159-9","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis","volume":"8","author":"Stolk","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib142","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00034983.1996.11813075","article-title":"Onchocerca volvulus and O.\u00a0lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in\u00a0vitro and in\u00a0vivo","volume":"90","author":"Tagboto","year":"1996","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib143","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CMR.00057-10","article-title":"Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment","volume":"24","author":"Tamarozzi","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib144","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-4758(00)01661-6","article-title":"Wolbachia bacteria of filarial nematodes: a target for control?","volume":"16","author":"Taylor","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0031182013001108","article-title":"Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis","volume":"141","author":"Taylor","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib146","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-3305-5-28","article-title":"Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control","volume":"5","author":"Tekle","year":"2012","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib147","first-page":"93","article-title":"Activity of the cyclooctadepsipeptide emodepside against onchocerca gutturosa, onchocerca lienalis and brugia pahangi","volume":"73","author":"Townson","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib148","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1371\/journal.pntd.0001825","article-title":"Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal","volume":"6","author":"Traore","year":"2012","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib149","doi-asserted-by":"crossref","first-page":"e2169","DOI":"10.1371\/journal.pntd.0002169","article-title":"Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis","volume":"7","author":"Turner","year":"2013","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13071-015-0779-4","article-title":"The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data","volume":"8","author":"Turner","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib151","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1756-3305-7-241","article-title":"Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections","volume":"7","author":"Turner","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib152","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1371\/journal.pntd.0000660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial","volume":"4","author":"Turner","year":"2010","journal-title":"PLoS.Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib153","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/mutage\/gev070","article-title":"Genotoxicity of flubendazole and its metabolites in\u00a0vitro and the impact of a new formulation on in\u00a0vivo aneugenicity","volume":"31","author":"Tweats","year":"2016","journal-title":"Mutagenesis"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib154","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1475-2883-2-S1-S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria. J."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2016.04.002_bib155","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1475-2883-2-S1-S3","article-title":"Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib156","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1365-3156.2003.01091.x","article-title":"Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis","volume":"8","author":"Twum-Danso","year":"2003","journal-title":"Trop.Med.Int Health"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib157","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S0031182004006523","article-title":"Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle","volume":"130","author":"von Samson-Himmelstjerna","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib158","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/cid\/ciu1152","article-title":"Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness","volume":"60","author":"Walker","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib159","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13071-015-0817-2","article-title":"Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment","volume":"8","author":"Wanji","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/09286586.2013.836230","article-title":"River blindness eliminated in Colombia","volume":"20","author":"West","year":"2013","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.ijpddr.2016.04.002_bib161","series-title":"Tropical Disease Research: Progress 2003-2004WHO\/TDR (TDR\/GEN\/05.1","author":"WHO\/TDR","year":"2005"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib162","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0031182002002639","article-title":"The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum","volume":"126","author":"Willson","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib163","series-title":"Onchocerciasis and its Control. Report of a WHO Expert Committee on Onchocerciasis ControlWorld Health Organization","author":"World Health Organization","year":"1995"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib164","series-title":"Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases. A Roadmap for Implementation (WHO\/HTM\/NTD\/2012.1)World Health Organization","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib165","series-title":"Provisional Strategy for Interruption Lymphatic Filariasis Transmission in Loiasis-endemic Countries. Report of the Meeting on Lymphatic Filariasis, Malaria and Integrated Vector Management, Accra, Ghana","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib166","series-title":"Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib167","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1756-3305-7-168","article-title":"The impact of Merowe dam on Simulium hamedense vector of onchocerciasis in Abu Hamed focus - northern Sudan","volume":"7","author":"Zarroug","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib168","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1756-3305-7-326","article-title":"The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis control: (2) pre-control endemicity levels and estimated number infected","volume":"7","author":"Zoure","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.04.002_bib169","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1371\/journal.pntd.0001210","article-title":"The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)","volume":"5","author":"Zoure","year":"2011","journal-title":"PLoS.Negl. Trop. Dis."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071630015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071630015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:56Z","timestamp":1761922016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221132071630015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S221132071630015X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.04.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research for new drugs for elimination of onchocerciasis in Africa","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Australian Society for Parasitology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}